Paper12709367
Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles.
Tammaro A and 9 others. Clin Chem, 2003. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles. Papers, record 12709367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12709367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Malignant Hyperthermia | Major topic |
| Ryanodine Receptor Calcium Release Channel | Major topic |
| Alleles | |
| Amino Acid Sequence | |
| Chromatography, High Pressure Liquid | |
| DNA Mutational Analysis | |
| Humans | |
| Molecular Sequence Data | |
| Mutation | |
| Nucleic Acid Denaturation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| TGM03Z02 | Telethon | Italy | PubMed | |
| TGM06S01 | Telethon | Italy | PubMed |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35178478 | Atypical symptoms of malignant hyperthermia: A rare causative mutation in the RYR1 gene. | Open Med (Wars) | 2022 | https://conductscience.org/library/papers/35178478 | PubMed |
| 34595679 | Mutational and clinical spectrum of centronuclear myopathy in 9 cases and a literature review of Chinese patients. | Neurol Sci | 2022 | https://conductscience.org/library/papers/34595679 | PubMed |
| 33564012 | Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance. | Sci Rep | 2021 | https://conductscience.org/library/papers/33564012 | PubMed |
| 31737266 | Whole exome sequencing revealed a pathogenic variant in a gene related to malignant hyperthermia in a Vietnamese cardiac surgical patient: A case report. | Ann Med Surg (Lond) | 2019 | https://conductscience.org/library/papers/31737266 | PubMed |
| 31559918 | Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of RYR1, CACNA1S and STAC3 variants. | Pharmacogenomics | 2019 | https://conductscience.org/library/papers/31559918 | PubMed |
| 30788618 | The histopathological spectrum of malignant hyperthermia and rhabdomyolysis due to RYR1 mutations. | J Neurol | 2019 | https://conductscience.org/library/papers/30788618 | PubMed |
| 27646467 | Hypermetabolism in B-lymphocytes from malignant hyperthermia susceptible individuals. | Sci Rep | 2016 | https://conductscience.org/library/papers/27646467 | PubMed |
| 24433488 | Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study. | Orphanet J Rare Dis | 2014 | https://conductscience.org/library/papers/24433488 | PubMed |
| 23558838 | Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States. | Anesth Analg | 2013 | https://conductscience.org/library/papers/23558838 | PubMed |
| 23183335 | Novel excitation-contraction uncoupled RYR1 mutations in patients with central core disease. | Neuromuscul Disord | 2013 | https://conductscience.org/library/papers/23183335 | PubMed |
| 19027160 | A recessive ryanodine receptor 1 mutation in a CCD patient increases channel activity. | Cell Calcium | 2009 | https://conductscience.org/library/papers/19027160 | PubMed |
| 16909197 | Novel regulators of RyR Ca2+ release channels: insight into molecular changes in genetically-linked myopathies. | J Muscle Res Cell Motil | 2006 | https://conductscience.org/library/papers/16909197 | PubMed |
| 15175001 | Central core disease mutations R4892W, I4897T and G4898E in the ryanodine receptor isoform 1 reduce the Ca2+ sensitivity and amplitude of Ca2+-dependent Ca2+ release. | Biochem J | 2004 | https://conductscience.org/library/papers/15175001 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RYR1 | 6261 | Swiss-Prot's references | https://conductscience.org/library/genes/6261 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| OMIM | 145600 |
Source OMIM
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12709367
GET https://conductscience.org/api/papers/v1/12709367/authors